Home Other Building Blocks 254737-29-6
254737-29-6,MFCD24479659
Catalog No.:AA01E3V2

254737-29-6 | 2-MPPA

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%
1 week  
$257.00   $180.00
- +
10mg
98%
1 week  
$384.00   $269.00
- +
50mg
98%
1 week  
$1,400.00   $980.00
- +
100mg
98%
1 week  
$2,431.00   $1,702.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01E3V2
Chemical Name:
2-MPPA
CAS Number:
254737-29-6
Molecular Formula:
C8H14O4S
Molecular Weight:
206.2594
MDL Number:
MFCD24479659
SMILES:
SCCCC(C(=O)O)CCC(=O)O
Properties
Computed Properties
 
Complexity:
181  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
1  
XLogP3:
0.6  

Literature

Title: Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds.

Journal: Journal of medicinal chemistry 20120628

Title: Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.

Journal: Brain research 20110131

Title: The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase II.

Journal: Bioorganic & medicinal chemistry letters 20101215

Title: Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.

Journal: European journal of pharmacology 20100210

Title: Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.

Journal: Drug discovery today 20070901

Title: The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy.

Journal: Journal of the neurological sciences 20060925

Title: Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.

Journal: Journal of medicinal chemistry 20060518

Title: 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice.

Journal: Psychopharmacology 20051201

Title: The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.

Journal: British journal of clinical pharmacology 20050801

Title: Enantiospecificity of glutamate carboxypeptidase II inhibition.

Journal: Journal of medicinal chemistry 20050407

Title: GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Journal: Journal of neurophysiology 20040101

Title: Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.

Journal: Bioorganic & medicinal chemistry letters 20030707

Title: Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.

Journal: Journal of medicinal chemistry 20030508

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:254737-29-6 Molecular Formula|254737-29-6 MDL|254737-29-6 SMILES|254737-29-6 2-MPPA